Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-4673
Fax+1 214-645-7316
Dr. Conzen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1990 - 1995
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1987 - 1990
Yale School of MedicineClass of 1987
Certifications & Licensure
TX State Medical License 2020 - 2026
IL State Medical License 1996 - 2020
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- AAP 2020
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Publications & Presentations
PubMed
- A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.Nan Chen, Margarite Matossian, Poornima Saha, Murtuza Rampurwala, Salaija Kamaraju
Breast Cancer Research and Treatment. 2025-05-01 - High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration.Margarite D Matossian, Christine Shiang, Deniz Nesli Dolcen, Marie Dreyer, Ken Hatogai
Breast Cancer Research and Treatment. 2025-02-01 - Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.Manisha Taya, Xiaonan Hou, Jennifer T Veneris, Nina Kazi, Melissa C Larson
Journal of Gynecologic Oncology. 2025-01-01
Other
- Managing the side effects of tamoxifenConzen SD
http://www.uptodate.com/contents/managing-the-side-effects-of-tamoxifen
UpToDate, Wolters Kluwer Health - 2012-07-16 - Mechanisms of action of selective estrogen receptor modulatorsConzen SD, Ellis M
http://www.uptodate.com/contents/mechanisms-of-action-of-selective-estrogen-receptor-modulators
UpToDate, Wolters Kluwer Health - 2013-02-19
Grant Support
- Effects of chronic pubertal stressors on mammary gland biology and cancer riskUNIVERSITY OF CHICAGO2020–2026
- Estrogen and glucocorticoid receptor crosstalk in ER+ breastUT SOUTHWESTERN MEDICAL CENTER2019–2025
- Identifying Mechanisms Linking Stress Biology To Human Breast CancerNational Cancer Institute2011–2012
- The Role Of SGK1 In Triple-Negative Breast Cancer Resistance To TreatmentNational Cancer Institute2010–2011
- Glucocorticoid Receptor-Mediated Survival Signaling In Breast CancerNational Cancer Institute2006–2010
- Social Isolation And Response To Mammary Cancer TherapyNational Institute Of Environmental Health Sciences2007
- Survival Signaling In Breast CancerNational Cancer Institute2001–2005
- Glucocorticoid Mediated Signaling In Breast CancerNational Cancer Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
